Leela Lavasani, MD
Otolaryngology · Naples, FLNPI 1083810493
Payments from drug & device makers
Across 365 payments — averaging $120.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$39K
- Sanofi$994
- Regeneron Healthcare Solutions, Inc.$817
- AstraZeneca$515
- GSK$358
- Novartis$245
- plus $2K from 25 others
What the payments were for
- Consulting fees$21,12848%
- Speaking & faculty fees$6,00014%
- Travel & lodging$5,11612%
- Food & beverage$11,46426%
- Education$1360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 200 | $39,340 |
| Sanofi | 29 | $994 |
| Regeneron Healthcare Solutions, Inc. | 28 | $817 |
| AstraZeneca | 24 | $515 |
| GSK | 16 | $358 |
| Novartis | 12 | $245 |
| Intersect ENT, Inc. | 1 | $148 |
| Acera Surgical, Inc. | 1 | $147 |
| Kaleo, Inc. | 8 | $133 |
| Sanofi-aventis U.S. LLC | 2 | $128 |
| Optinose US, Inc. | 6 | $111 |
| Merck | 4 | $100 |
| Medtronic | 2 | $96 |
| Organogenesis Inc. | 4 | $89 |
| Xoran Technologies LLC | 1 | $88 |
| Genentech USA, Inc. | 5 | $88 |
| Mimedx Group, Inc. | 2 | $58 |
| Phadia US Inc. | 3 | $51 |
| Hikma Pharmaceuticals USA | 3 | $46 |
| Acclarent, Inc | 1 | $43 |
| Davol Inc. | 2 | $40 |
| Vertex | 1 | $26 |
| Ambu Inc. | 2 | $26 |
| Checkpoint Surgical, Inc | 1 | $24 |
| Stimlabs LLC | 1 | $23 |
| Kerecis Limited | 1 | $21 |
| Focal Therapeutics, Inc. | 1 | $21 |
| Stryker | 1 | $20 |
| Atos Medical Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$32,785
- Inspire Upper Airway Stimulation System$4,049
- PROPEL$148
- Restrata Wound Matrix$147
- FASENRA$117
- NUCALA$106
How this compares
$43,844 in reported general payments places this provider in the 90th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $70,697 |
| XolairOmalizumab | 20 | $54,405 |
| Ipratropium Bromide | 104 | $4,402 |
| Fluticasone Propionate | 66 | $1,303 |
| Fluocinolone Acetonide Oil | 24 | $1,146 |
| Omeprazole | 72 | $942 |
| Azelastine Hcl | 39 | $823 |
| SynthroidLevothyroxine Sodium | 11 | $595 |
| Levocetirizine Dihydrochloride | 22 | $418 |
| Triamcinolone Acetonide | 20 | $360 |
| Pantoprazole Sodium | 26 | $335 |
| Montelukast Sodium | 25 | $327 |
| Tramadol Hcl | 90 | $295 |
| Famotidine | 29 | $294 |
| Levothyroxine Sodium | 24 | $280 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Naples
- James HadleyNaples$33K
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Cecelia DamaskOrlando$771K
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
- Franklin RimellFort Myers$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.